Medical Device | June 04, 2026
HeartBeam study shows pocket-sized ECG device can predict heart attack risk
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
Baxfendy works in a fundamentally different way from current therapies
Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone
The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
